BRCA1 and non-small cell lung carcinoma: For instance, it has been reported that the aberrant expression of BRCA1 impairs the DNA damage repair machinery in certain tumors, and therefore, its expression levels can be an effective biomarker of survival for non-small-cell lung cancer patients with cisplatin-based chemotherapy (88).